Right now in the biotech space, “some of the most exciting publicly traded…companies are capitalizing on our ever-growing ability to map and manipulate genes,” observes the author of today’s article. With that, he proceeds to highlight three particular biotech companies operating in the gene therapy space to consider – all of which are up by more than 300% in the past year. For more, CLICK HERE.
3 Gene Therapy Stocks With The Right Stuff
- by RobH
Tags:300% IncreaseBiotech CompaniesBiotech InvestmentsBiotech SpaceGene Therapy SpaceGene Therapy StocksHealth SectorInvestingPublicly TradedStock MarketStocks to Buy